Market Research & Insights

Impact of COVID-19 pandemic on medical devices market

Health Industry Hub | April 27, 2020 |
[Total: 1    Average: 5/5]

Market Research & Insights: The COVID-19 pandemic is leading to significant growth in demand for medical devices such as ventilators, medical clothing, face masks, and diagnostic devices such as test kits, whereas the revenue of companies, whose products rely heavily on elective and non-essential procedures, are expected to be impacted negatively.

Many medical device companies have revised their financial guidance for 2020 due to the uncertainty associated with the degree and duration of the impact of the outbreak.

The short-term impact of COVID-19 is expected to cause a decline in annual growth rate of the global medical devices market from 5.4% to 3.0% in 2020. The global medical devices market, which was projected to be worth USD 472 billion in 2020 before the COVID-19 outbreak, is now expected to generate USD 461 billion this year.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content with high engagement and 20+ years industry experience. Created by industry for industry. Contact us.

Key Reasons for the Impact

Delay in Elective Surgery

Elective procedures have been delayed as countries divert their healthcare resources to contain the COVID-19 pandemic.

The impact of the delay in elective procedures on the demand for medical devices is significant as these types of procedures account for around 40% – 50% of the hospital’s revenues in some countries.

Supply Chain Disruptions

The supply of medical devices or the raw material required for the manufacturing of medical devices have been disrupted as many countries went into lock-down. The forced quarantine in China hit the supply-chain the hardest as the country transitioned from being a key player in the manufacturing of low-end to high-end medical devices.

With a significant increase in the demand for certain medical devices, some countries halted exports, especially the devices that are vital in fighting against the COVID-19 outbreak.

Impact of China

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

China, which accounted for around 7% of the global medical devices market, was projected to grow at a CAGR of around 10% in the 2018 – 2025 period before the outbreak. The demand for medical devices is expected to decline considerably in the first quarter of 2020 in China and impact the revenues of all major medical device companies.

Segments with Low Level Exposure to COVID-19

  • In-vitro Diagnostics
  • Diagnostic Imaging
  • Respiratory Care
  • General Hospital and Healthcare Supplies

Segments with High Level Exposure to COVID-19

  • Orthopaedic Devices
  • Cardiovascular Devices
  • Minimally Invasive Surgical Devices
  • Dental Equipment and Devices
  • Diabetes Care Devices
  • Ophthalmic Devices

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - The power of being an authentic leader

The power of being an authentic leader

Health Industry Hub | April 21, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]


Digital & Innovation

Healthcare Technology Digital Innovations - Data is the biggest challenge, and opportunity, for MedTech

Data is the biggest challenge, and opportunity, for MedTech

Health Industry Hub | April 21, 2021 |

Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]


News & Trends - Medical Technology

MedTech News - Thermo Fisher acquisition to better serve its pharma and biotech clients

Thermo Fisher acquisition to better serve its pharma and biotech clients

Health Industry Hub | April 21, 2021 |

MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]


News & Trends - Pharmaceuticals

Pharma News - First-in-class oncology drug candidate licensed by Aussie pharma

First-in-class oncology drug candidate licensed by Aussie pharma

Health Industry Hub | April 21, 2021 |

Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]